Abstract:
Introduction. Neurological manifestations are found in more than 1/3 of cases
of SARS-Cov-2 infection. Actually acute epileptic seizures and Epileptic Status (SE)
in children currently demonstrate a high mortality rate ( between 5% and 39%) in
combination and post-infection with SARS-CoV-2.Purpose. To estimate the prevalence of the association of neurological
manifestations, including acute seizures and status epilepticus (SE) after infection
with Covid-19 in children. Material and methods. Prospective study was conducted on a group of 47
children with age reference from 6 months to 10 years, who were hospitalized in
the Neurology Department and IMSP Mother and Child Institute and selected
according to the association of neurological symptoms especially those who
associated SE during and after infection with Covid-19.Examinations: EEG,
imaging. The SPSS program was used for statistical analysis. Results. Within this group of children neurological recurrences during and
post-SARS-CoV-2 was as follows: 30 (63,8%) represented in-hospital onset,
whereas 12 (25.5%) had outpatient onset, and 5 (10.6%) presented with unclear
onset. Neurological symptoms consistent with SE was diagnosed in (31.2%),
whereas other frequently reported symptoms were hypo/anosmia (11.7%) ,
encephalopathies (9.3%), stroke(5.6%), hyperkinesia (5.6%), irritability (27.8%),
cognitive impairment (22.2%), and asthenia(18.7%). EEG findings and imaging
data correlated with cerebral distress (r = 0.62), (r = 0.78), respectively. No
significant difference was noticed between the recurrence of in-hospital (p> 0.01)
and out-of-hospital SE (p> 0.02). Conclusions. Although a possible association between SE and
Covid-19 has been reported, the neuroinvasive and neurotropic
properties of SARS-CoV-2 are insufficiently elucidated. The
cytokine storm and hyperactivation of immune cells lead to
secondary dysfunction in CNS with subsequent occurrence of
neurological sequelae.
Description:
Pediatric Neurology Clinic, Pediatrics Department, USMF „Nicolae Testemitanu”,
IMSP Mother and Child Institute, Chisinau, Republic of Moldova,
National Center for Epileptology